CC-96673

· Celgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CC-96673, covering 2024-10-16 to 2024-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Finding Study of CC-96673 in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]